Columbia University HIV Vaccine Unit

New York, New York 10032

0 studies enrolling now · 1 studies all time

What they study most

Healthy

Studies at this site

• A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Tetravalent Ad26.Mos4.HIV Along With Either Clade C gp140 Plus Adjuvant OR With a Combination of Mosaic and Clade C gp140 Plus Adjuvant in Healthy HIV Uninfected Adults — Completed